- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Insight 69 results
Thought Leadership
Thought Leadership
2月 25, 2021
ESG Agenda – Larry’s Letter, Overhaul of ISS Quality Score, COVID Pay Adjustment Benchmarking
Thought Leadership
2月 19, 2021
Viren Mascarenhas Appointed as Vice Chair of CPR Arbitration Committee
Thought Leadership
12月 17, 2020
2020 Post-Election Commentary
Thought Leadership
12月 16, 2020
ESG Agenda – Early Human Capital Disclosures, Major Voting Policy Changes, NASDAQ’s Diversity Demand
Thought Leadership
12月 2, 2020
Key Takeaways From the 13th Annual King & Spalding Medical Device Summit
Thought Leadership
11月 6, 2020
King & Spalding Co-Authors Discussion Paper on Tax Amnesties
Thought Leadership
10月 28, 2020
Key Proxy Statement Disclosure Trends: Executive Compensation
Thought Leadership
10月 26, 2020
ESG Agenda – ISS Policy Changes, New Board Diversity Law, Political Activity Disclosure
Thought Leadership
10月 15, 2020
Key Proxy Statement Disclosure Trends Beyond Compliance
Thought Leadership
10月 5, 2020
Key Proxy Statement Disclosure Trends: Corporate Governance
Thought Leadership
9月 18, 2020
Isabel San Martin Appointed to ERA Pledge Young Practitioners Subcommittee